Company news

HBM Holdings Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities

March 24, 2022

Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003

January 4, 2022

Harbour BioMed: Announces NMPA Approval of Two IND Applications for Next-Generation Anti-CTLA-4 Antibody HBM4003

September 14, 2021

Voluntary announcement - dosing of first patient in phase ib/IIa clinical study of next-generation anti-ctla-4 antibody in australia

May 12, 2021

← Newer news releases

Decks

The 5 newest of 9 decks. Every deck is listed under its year.